A case report of sepsis associated coagulopathy after percutaneous nephrostomy.


Journal

BMC urology
ISSN: 1471-2490
Titre abrégé: BMC Urol
Pays: England
ID NLM: 100968571

Informations de publication

Date de publication:
28 May 2024
Historique:
received: 25 10 2023
accepted: 03 04 2024
medline: 29 5 2024
pubmed: 29 5 2024
entrez: 28 5 2024
Statut: epublish

Résumé

Hemorrhage is a common complication of nephrostomy and percutaneous nephrolithotripsy, and it is caused by surgical factors. Here we report a rare case of hemorrhage caused by sepsis-related coagulation dysfunction. A 72-years-old male patient with bilateral ureteral calculi accompanied by hydronephrosis and renal insufficiency developed sepsis and hemorrhage on the third day after bilateral nephrostomy. After vascular injury was excluded by DSA, the hemorrhage was considered to be sepsis-associated coagulopathy(SAC/SIC), finally the patient recovered well after active symptomatic treatment. In patients with sepsis and hemorrhage, SAC/SIC cannot be excluded even if coagulation function is slightly abnormal after surgical factors are excluded. For urologists who may encounter similar cases in their general urology practice, it is important to be aware of these unusual causes of hemorrhage.

Sections du résumé

BACKGROUND BACKGROUND
Hemorrhage is a common complication of nephrostomy and percutaneous nephrolithotripsy, and it is caused by surgical factors. Here we report a rare case of hemorrhage caused by sepsis-related coagulation dysfunction.
CASE PRESENTATION METHODS
A 72-years-old male patient with bilateral ureteral calculi accompanied by hydronephrosis and renal insufficiency developed sepsis and hemorrhage on the third day after bilateral nephrostomy. After vascular injury was excluded by DSA, the hemorrhage was considered to be sepsis-associated coagulopathy(SAC/SIC), finally the patient recovered well after active symptomatic treatment.
CONCLUSIONS CONCLUSIONS
In patients with sepsis and hemorrhage, SAC/SIC cannot be excluded even if coagulation function is slightly abnormal after surgical factors are excluded. For urologists who may encounter similar cases in their general urology practice, it is important to be aware of these unusual causes of hemorrhage.

Identifiants

pubmed: 38807082
doi: 10.1186/s12894-024-01476-x
pii: 10.1186/s12894-024-01476-x
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

113

Informations de copyright

© 2024. The Author(s).

Références

Giustozzi M, Ehrlinder H, Bongiovanni D, Borovac JA, Guerreiro RA, Gasecka A, Papakonstantinou PE, Parker WAE. Coagulopathy and sepsis: pathophysiology, clinical manifestations and treatment. Blood Rev. 2021;50:100864.
doi: 10.1016/j.blre.2021.100864 pubmed: 34217531
Scarlatescu E, Tomescu D, Arama SS. Sepsis-Associated Coagulopathy. J Crit Care Med (Targu Mures). 2016;2(4):156–63.
doi: 10.1515/jccm-2016-0024 pubmed: 29967855
Wheeler AP, Bernard GR. Treating patients with severe sepsis. N Engl J Med. 1999;340(3):207–14.
doi: 10.1056/NEJM199901213400307 pubmed: 9895401
Iba T, Helms J, Connors JM, Levy JH. The pathophysiology, diagnosis, and management of sepsis-associated disseminated intravascular coagulation. J Intensive Care. 2023;11(1):24.
doi: 10.1186/s40560-023-00672-5 pubmed: 37221630 pmcid: 10202753
Iba T, Umemura Y, Wada H, Levy JH. Roles of Coagulation abnormalities and microthrombosis in Sepsis: pathophysiology, diagnosis, and treatment. Arch Med Res. 2021;52(8):788–97.
doi: 10.1016/j.arcmed.2021.07.003 pubmed: 34344558
Kobayashi N, Maekawa T, Takada M, Tanaka H, Gonmori H. Criteria for diagnosis of DIC based on the analysis of clinical and laboratory findings in 345 DIC patients collected by the Research Committee on DIC in Japan. Bibl Haematol. 1983;49:265–75.
Wang M, Kou H, Deng J, Wang H, Guo T, Mei H, Hu Y. Retrospective evaluation of New Chinese Diagnostic Scoring System for disseminated intravascular coagulation. PLoS ONE. 2015;10(6):e0129170.
doi: 10.1371/journal.pone.0129170 pubmed: 26076032 pmcid: 4467973
Iba T, Di Nisio M, Thachil J, Wada H, Asakura H, Sato K, Saitoh D. A proposal of the modification of Japanese society on thrombosis and Hemostasis (JSTH) disseminated intravascular coagulation (DIC) Diagnostic Criteria for Sepsis-Associated DIC. Clin Appl Thromb Hemost. 2018;24(3):439–45.
doi: 10.1177/1076029617720069 pubmed: 28747069
Iba T, Levy JH, Warkentin TE, Thachil J, van der Poll T, Levi M, Scientific S et al. Standardization Committee on P : Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation. J Thromb Haemost 2019, 17(11):1989–1994.
Gando S, Meziani F, Levi M. What’s new in the diagnostic criteria of disseminated intravascular coagulation? Intensive Care Med. 2016;42(6):1062–4.
doi: 10.1007/s00134-016-4257-z pubmed: 26858172
Iba T, Nisio MD, Levy JH, Kitamura N, Thachil J. New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey. BMJ Open. 2017;7(9):e017046.
doi: 10.1136/bmjopen-2017-017046 pubmed: 28963294 pmcid: 5623518
Poudyal S. Current insights on haemorrhagic complications in percutaneous nephrolithotomy. Asian J Urol. 2022;9(1):81–93.
doi: 10.1016/j.ajur.2021.05.007 pubmed: 35198401
Kessaris DN, Bellman GC, Pardalidis NP, Smith AG. Management of hemorrhage after percutaneous renal surgery. J Urol. 1995;153(3 Pt 1):604–8.
doi: 10.1016/S0022-5347(01)67659-6 pubmed: 7861493
Ganpule AP, Shah DH, Desai MR. Postpercutaneous nephrolithotomy bleeding: aetiology and management. Curr Opin Urol. 2014;24(2):189–94.
doi: 10.1097/MOU.0000000000000025 pubmed: 24445556
Tsantes AG, Parastatidou S, Tsantes EA, Bonova E, Tsante KA, Mantzios PG, Vaiopoulos AG, Tsalas S, Konstantinidi A, Houhoula D et al. Sepsis-Induced Coagulopathy: an update on pathophysiology, biomarkers, and current guidelines. Life (Basel) 2023, 13(2).
Lyons PG, Micek ST, Hampton N, Kollef MH. Sepsis-Associated Coagulopathy Severity predicts Hospital Mortality. Crit Care Med. 2018;46(5):736–42.
doi: 10.1097/CCM.0000000000002997 pubmed: 29373360
Schmoch T, Mohnle P, Weigand MA, Briegel J, Bauer M, Bloos F, Meybohm P, Keh D, Loffler M, Elke G, et al. The prevalence of sepsis-induced coagulopathy in patients with sepsis - a secondary analysis of two German multicenter randomized controlled trials. Ann Intensive Care. 2023;13(1):3.
doi: 10.1186/s13613-022-01093-7 pubmed: 36635426 pmcid: 9837358
Zeng J, Ding H, Zhong W, Li X, Zeng H. [Predictive value of sepsis-induced coagulopathy score on 30-day mortality in septic patients]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022;34(12):1263–7.
pubmed: 36567580
Tanaka C, Tagami T, Kudo S, Takehara A, Fukuda R, Nakayama F, Kaneko J, Ishiki Y, Sato S, Kuno M, et al. Validation of sepsis-induced coagulopathy score in critically ill patients with septic shock: post hoc analysis of a nationwide multicenter observational study in Japan. Int J Hematol. 2021;114(2):164–71.
doi: 10.1007/s12185-021-03152-4 pubmed: 33895968 pmcid: 8067778
Iba T, Arakawa M, Di Nisio M, Gando S, Anan H, Sato K, Ueki Y, Levy JH, Thachil J. Newly proposed Sepsis-Induced Coagulopathy Precedes International Society on thrombosis and haemostasis overt-disseminated intravascular coagulation and predicts high mortality. J Intensive Care Med. 2020;35(7):643–9.
doi: 10.1177/0885066618773679 pubmed: 29720054

Auteurs

Juan Duan (J)

Department of urology, 920thhospital of Joint Logistics Support Force, Kunming, PLA, China.

Tao Ye (T)

Department of urology, 920thhospital of Joint Logistics Support Force, Kunming, PLA, China.

Yueyue Yang (Y)

Department of urology, 920thhospital of Joint Logistics Support Force, Kunming, PLA, China.

Yiping Zhou (Y)

Department of urology, 920thhospital of Joint Logistics Support Force, Kunming, PLA, China.

Shengyu Yang (S)

Department of urology, 920thhospital of Joint Logistics Support Force, Kunming, PLA, China.

Yueli Wang (Y)

Department of urology, 920thhospital of Joint Logistics Support Force, Kunming, PLA, China. wylmn43@163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH